Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.
about
E-type prostanoid receptor 4 (EP4) in disease and therapyInterplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritisReducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis.Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis.Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism.Prostacyclin regulates bone growth via the Epac/Rap1 pathway.Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritisOsteoRheumatology: a new discipline?RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritisThe pain-relieving qualities of exercise in knee osteoarthritis.Silicate modulates the cross-talk between osteoblasts (SaOS-2) and osteoclasts (RAW 264.7 cells): inhibition of osteoclast growth and differentiation.Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis.A significant association exists between receptor tyrosine kinase-like orphan receptor 2 gene variants and the OPG/RANKL ratio in human plasma.Wnt inhibitory factor 1 deficiency uncouples cartilage and bone destruction in tumor necrosis factor α-mediated experimental arthritis.
P2860
Q26851156-5AE84A2D-0C10-456A-BBE8-549633CDF77BQ26862126-174607FF-6752-4BB2-926C-C6F08F95B72EQ33951246-F1F68210-DAB6-4BF9-A28D-93CBA980DB2BQ34153080-AACB95AC-6EDB-47DF-B2EE-ED0D22F0F013Q34202961-19237F60-FA3E-4DBA-995A-8B70A97605EEQ34982327-C82F02B6-526C-4255-B5B2-9CE155F69F98Q35840709-63E86C50-7543-469A-AEF9-EF5A3084ECDFQ36246080-02CC63F2-2E90-4A0B-B913-52A258BA932FQ36246148-142DCB32-0C18-47A9-9766-8074F2D77505Q37358282-10B96A4E-D20F-4882-BFAC-4481BFD66F67Q39344647-3E4F6DB5-A529-40A4-B289-FD2A8BD8C33CQ42751154-BD19C853-EDBD-4238-B921-E539597E29FBQ47252258-75F5EA2B-7108-4CE7-B34E-67C91C63DCDAQ50892898-A4BBE085-6388-4C3E-9321-5CE89C050957
P2860
Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Nonsteroidal antiinflammatory drugs and prostaglandin E
@nl
Nonsteroidal antiinflammatory ...... th severe knee osteoarthritis.
@en
type
label
Nonsteroidal antiinflammatory drugs and prostaglandin E
@nl
Nonsteroidal antiinflammatory ...... th severe knee osteoarthritis.
@en
prefLabel
Nonsteroidal antiinflammatory drugs and prostaglandin E
@nl
Nonsteroidal antiinflammatory ...... th severe knee osteoarthritis.
@en
P50
P356
P1476
Nonsteroidal antiinflammatory ...... ith severe knee osteoarthritis
@en
P2093
Lidia Tardio
P2860
P304
P356
10.1002/ART.27204
P577
2010-02-01T00:00:00Z